Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2009
10/08/2009US20090253912 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content
10/08/2009US20090253755 N-[(pyridin-2-yl) methoxy] benzamide derivatives and related compounds as fungicides
10/08/2009US20090253690 N-[3-(1-piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine; cardiovascular disorders; treating dysfunction of endothelial cells
10/08/2009US20090253688 Semicarbazide derivatives as kinase inhibitors
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009US20090252676 N-alkoxyamide conjugates as imaging agents
10/08/2009CA2720350A1 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/08/2009CA2720319A1 Continuous method for producing amides of aromatic carboxylic acids
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009CA2718310A1 Pyridyl derivatives as cftr modulators
10/08/2009CA2717537A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/07/2009EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/07/2009EP2106396A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/07/2009EP1553086B1 Process for producing 5-(2 '-pyridyl)-2-pyridone derivative
10/07/2009EP1308441B1 2-aminopyridine compounds and use thereof as drugs
10/07/2009EP1275630B1 Process for producing substituted aromatic compound
10/07/2009CN101553461A 4-substituted phenoxyphenylacetic acid derivatives
10/07/2009CN101550165A Double platinum (II) pyridine complex of organic photoelectric materials, synthetic method and applications
10/07/2009CN101550085A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/07/2009CN101550046A A method for synthesis of medium-ring compounds of 9 to 12 rings
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/06/2009US7598423 e.g. 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
10/06/2009US7598419 Such as N-(Cyanoacetyl)-3,4-dimethoxybenzylamide
10/06/2009US7598418 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598395 Heterocyclocarboxamide derivatives
10/06/2009US7598391 Heteroaryl-ureas and their use as glucokinase activators
10/06/2009US7598387 Synthesis of antidiabetic rosiglitazone derivatives
10/06/2009US7598386 Sulphones which modulate the action of gamma-secretase
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598380 Method of preparation of azaindole derivatives
10/06/2009US7598292 such as {2-Methyl-4-[2-(4-trifluoromethyl-phenoxymethyl )-allylsulfanyl]-phenoxy}-acetic acid, used as peroxisome proliferator-activated receptors modulators for treating or inhibit the progression of dyslipidemia
10/06/2009US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009US7598276 Pharmaceutical salts and polymorphs of a factor Xa inhibitor
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009US7598241 Carboxamide derivatives and their use as factor Xa inhibitors
10/06/2009US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
10/06/2009CA2488034C Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
10/06/2009CA2482530C 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
10/06/2009CA2419764C Process for preparing a substituted imidazopyridine compound
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/06/2009CA2258924C Cftr channel activator compounds and pharmaceutical compositions containing same
10/01/2009WO2009119700A1 Manufacturing method for a piperidine-3-ylcarbamate compound and optical resolution method therefor
10/01/2009WO2009119167A1 Aniline derivative having anti-rna viral activity
10/01/2009WO2009119085A1 Novel photosensitizer and photovoltaic element
10/01/2009WO2009118516A1 Process for the preparation of donepezil hydrochloride
10/01/2009WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009WO2009118168A1 Substituted 4-aminocyclohexane derivatives
10/01/2009US20090247764 Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-x, heteroaryl-x, cycloalkenyl-x or alkenyl-x compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide
10/01/2009US20090247763 Fungicidal composition and method for controlling plant diseases
10/01/2009US20090247755 Process for Preparing a Substituted Imidazopyridine Compound
10/01/2009US20090247731 Boronic ester and acid compounds, synthesis and uses
10/01/2009US20090247590 Indane amides
10/01/2009US20090247588 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/01/2009US20090247534 New compounds
10/01/2009US20090247522 Hsp90 FAMILY PROTEIN INHIBITORS
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247506 Antibacterial agents
10/01/2009US20090247489 Dihydroxyl compounds and compositions for cholesterol management and related uses
10/01/2009US20090247473 Acythiols and component thiol compositions as anti-hiv and anti-retroviral agents
10/01/2009US20090246137 Pyridyl derivatives as cftr modulators
10/01/2009US20090242837 Charge transport compositions and electronic devices made with such compositions
10/01/2009CA2719735A1 Substituted 4-aminocyclohexane derivatives
10/01/2009CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009CA2719243A1 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
10/01/2009CA2719164A1 Process for the preparation of donepezil hydrochloride
09/2009
09/30/2009EP2105436A1 Lactam-containing compounds and derivatives thereof as factor XA inhibitors
09/30/2009EP2105435A1 Hydrazone derivative
09/30/2009EP2104662A2 Chelating agents
09/30/2009EP2104497A2 Urea and sulfamide derivatives as tafia inhibitors
09/30/2009CN101547903A 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate
09/30/2009CN101547902A Compounds for the treatment of metabolic disorders
09/30/2009CN101547901A Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
09/30/2009CN101544673A ECL marker of binuclear bipyridyl ruthenium/osmium connected by saturated carbon chains of different lengths
09/30/2009CN101544600A Method for separating and preparing ricinine
09/30/2009CN101544599A Crystal of 1,2-dihydropyridine compound
09/30/2009CN101544578A Preparing method for phenyl acetic acid derivates and applications in medicament
09/30/2009CN100545149C Method for the manufacture of cyanopyridines and catalysts suitable therefor
09/29/2009US7595501 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595344 Sulphones which modulate the action of gamma secretase
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
09/29/2009US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example
09/29/2009US7595309 For therapy of bacterial infections and neoplasms,
09/29/2009CA2550372C Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
09/29/2009CA2375670C 5-phenyl-pyrimidine derivatives
09/29/2009CA2334923C Aryl substituted olefinic amines and their use as cholinergic receptors agonists
09/29/2009CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
09/24/2009WO2009117278A2 Processes for preparing (amino-pyrazolopyridinyl)methoxy substituted biaryl ethers
09/24/2009WO2009115665A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
09/24/2009WO2009115651A2 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
09/24/2009WO2009115517A2 Organic compounds
09/24/2009WO2009087285A4 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
09/24/2009WO2009087212A3 Pyridine derivatives
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 633